The Patent Finder

Beijing Showby Pharmaceutical Co., Ltd.

7 patents currently held · Updated Nov 20, 2026
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Jul 2032
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Mar 22, 2027
    The maintenance fee for Platinum compounds for treating cell proliferative diseases, preparation method and use thereof (US 9,138,421) comes due Mar 22, 2027. Unpaid by Sep 22, 2027, it lapses early.
  • 1 fee due May 3, 2027
    The maintenance fee for Platinum compound having amino or alkylamino-containing succinic acid derivatives as leaving group, preparation method thereof, and use thereof (US 9,175,024) comes due May 3, 2027. Unpaid by Nov 3, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 7 of 7

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,138,421Platinum compounds for treating cell proliferative diseases, preparation method and use thereof
In force
 · USPTO record
In forceUSPTO record
US 9,175,024Platinum compound having amino or alkylamino-containing succinic acid derivatives as leaving group, preparation method thereof, and use thereof
In force
 · USPTO record
In forceUSPTO record
US 9,725,477Platinum compounds of malonic acid derivative having leaving group containing amino or alkylamino
In force
 · USPTO record
In forceUSPTO record
US 9,751,875Quinine compounds, and optical isomers, preparation method and medical use thereof
In force
 · USPTO record
In forceUSPTO record
US 11,447,485Class of bifunctional compounds with quanternary ammonium salt structure
In force
 · USPTO record
In forceUSPTO record
US 11,661,434Phosphate of Platinum Compound and Preparation Method Therefor
In force
 · High confidence
In forceHigh confidence
US 12,358,908Crystals, Preparation Method and Application of a Muscarinic Receptor Antagonist
In force
 · High confidence
In forceHigh confidence

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

Every application published under this name has become a patent.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited